Exosomal LRG1 derived from highly metastatic non-small cell lung cancer cells accelerates growth, metastasis, and angiogenesis by transcriptional factor NFKB1-mediated SHH upregulation
Cellular Signalling · 2026
DOI: 10.1016/j.cellsig.2025.112276 ↗Kurz gefasst
Fachartikel in der Zeitschrift Cellular Signalling, 2026. Verfasst von Hao Wu und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Thoracic Surgery, Shenzhen Second People's Hospital, Shenzhen 518035, China. Hauptthemen laut MEDLINE: Exosomes, Carcinoma, Non-Small-Cell Lung, Neovascularization, Pathologic, Lung Neoplasms. Die Arbeit nennt 51 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Shenzhen Science and Technology Innovation Commission.
Abstract (Originalsprache)
Neovascularization, a critical interstitial component, facilitates rapid tumor cell proliferation, metastasis, and recurrence. Communication between tumor-derived exosomes and endothelial cells promotes tumor progression and angiogenesis. Leucine-rich α2 glycoprotein-1 (LRG1) is abundant in exosomes released by non-small cell lung cancer (NSCLC) tissues and cells. However, the molecular mechanisms underlying exosomal LRG1's regulation of angiogenesis in NSCLC remain unclear. In this study, our study demonstrated that exosomes derived from NSCLC cells with high metastatic potential (HM) could enhance growth, metastasis, and angiogenesis. LRG1 was abundant in these HM NSCLC cell-released exosomes and could be transferred to endothelial cells via exosomes. Exosomal LRG1 stimulated the proliferation, migration, invasion, and tube-forming capacity of endothelial cells in vitro, as well as promoted angiogenesis, tumor growth, and metastasis in vivo. Mechanistic investigations revealed that exosomal LRG1 upregulated Sonic Hedgehog (SHH) by binding to Nuclear Factor-κB subunit 1 (NFKB1) within the SHH promoter. Furthermore, the knockdown of SHH could reverse the proliferation, migration, invasion, and angiogenesis of endothelial cells induced by exosomal LRG1. In conclusion, our study findings reveal that exosomal LRG1 accelerates the progression of NSCLC by NFKB1-induced SHH upregulation, offering a novel research perspective for the diagnosis and treatment of this patient population.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Thoracic Surgery, Shenzhen Second People's Hospital, Shenzhen 518035, China.
- Department of Respiratory and Critical Care Medicine, Peking University Shenzhen Hospital, Shenzhen 518035, China.
- Department of Thoracic Surgery, Shenzhen Second People's Hospital, Shenzhen 518035, China. Electronic address: szwuhao@email.szu.edu.cn.
Förderung
- Shenzhen Science and Technology Innovation Commission
Zitieren
APA
Wu, H., Zeng, C., Wu, G., Fang, F., Xiao, C., Li, L., Luo, Y., Zhou, C., & Qian, Y. (2026). Exosomal LRG1 derived from highly metastatic non-small cell lung cancer cells accelerates growth, metastasis, and angiogenesis by transcriptional factor NFKB1-mediated SHH upregulation. Cellular Signalling. https://doi.org/10.1016/j.cellsig.2025.112276
Vancouver
Wu H, Zeng C, Wu G, Fang F, Xiao C, Li L, et al. Exosomal LRG1 derived from highly metastatic non-small cell lung cancer cells accelerates growth, metastasis, and angiogenesis by transcriptional factor NFKB1-mediated SHH upregulation. Cellular Signalling. 2026. doi:10.1016/j.cellsig.2025.112276
BibTeX
@article{Wu2026,
author = {Wu, Hao and Zeng, Chao and Wu, Guodong and Fang, Fuyuan and Xiao, Chunyang and Li, Liang and Luo, Yisheng and Zhou, Chaochao and Qian, Youhui},
title = {Exosomal LRG1 derived from highly metastatic non-small cell lung cancer cells accelerates growth, metastasis, and angiogenesis by transcriptional factor NFKB1-mediated SHH upregulation},
journal = {Cellular Signalling},
year = {2026},
doi = {10.1016/j.cellsig.2025.112276}
}
EUVIMED